Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NexGel Equity Warrant Exp 17th Dec 2026 NXGLW

Healthcare Medical Instruments & Supplies
NexGel, Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing... see more

Recent & Breaking News (NDAQ:NXGLW)

NEXGEL Acquires International Beauty Brand, Silly George

GlobeNewswire 3 days ago

NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year

GlobeNewswire 6 days ago

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

GlobeNewswire 10 days ago

NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024

GlobeNewswire 13 days ago

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024

GlobeNewswire April 18, 2024

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

GlobeNewswire April 1, 2024

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

GlobeNewswire March 27, 2024

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

GlobeNewswire March 21, 2024

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

GlobeNewswire March 4, 2024

NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders

GlobeNewswire February 21, 2024

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

GlobeNewswire January 18, 2024

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

GlobeNewswire January 9, 2024

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

GlobeNewswire December 11, 2023

NEXGEL Acquires Kenkoderm Psoriasis Skincare Line

GlobeNewswire December 5, 2023

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

GlobeNewswire November 13, 2023

NEXGEL to Report Third Quarter 2023 Financial Results on November 13th

GlobeNewswire November 2, 2023

NEXGEL Secures Supply Agreement with AbbVie

GlobeNewswire October 30, 2023

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

GlobeNewswire September 26, 2023

NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year

GlobeNewswire August 14, 2023

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

GlobeNewswire August 2, 2023